News Daily News Hybrid Revascularization for Multivessel CAD Rarely Used in the US Todd Neale July 04, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Daily News PCI on the Rise Among the Elderly, Who Are Reaping Survival Gains Caitlin E. Cox April 23, 2019
News Daily News Most STEMI Patients Head to ICU After PCI, but Not All Need to Go Michael O'Riordan April 15, 2019
News Daily News There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends Todd Neale April 10, 2019
News Daily News Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission L.A. McKeown April 09, 2019
News Daily News Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality Michael O'Riordan March 06, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection Todd Neale January 18, 2019
News Daily News STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance Yael L. Maxwell January 09, 2019
Presentation Controversies and Advances 2018 Does Myocardial Viability Predict Improvement With Revascularization? Presenter: Robert O. Bonow November 16, 2018
Presentation Controversies and Advances 2018 Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Presenter: Daniel S. Berman November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients Caitlin E. Cox November 11, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News Complete Revascularization Improves Long-term NSTEMI Outcomes, Cohort Study Suggests Todd Neale October 16, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Daily News Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock L.A. McKeown July 03, 2018